Business
Adaptogenics Health Corp. Announces Strategic Review of Health & Wellness Opportunities and Management Changes
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") announces that its board of directors has initiated a strategic review to evaluate potential business opportunities within the broader health and wellness sector.As part of this review, the Company's board of directors and senior management are examining a range of potential strategic initiatives, which may include prospective business line transitions, strategic...
About this update from Adaptogenics Health Corp.
[{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company") announces that its board of directors has initiated a strategic review to evaluate potential business opportunities within the broader health and wellness sector.","length":314,"tagName":"p"},{"type":"text","content":"As part of this review, the Company's board of directors and senior management are examining a range of potential strategic initiatives, which may include prospective business line transitions, strategic partnerships, acquisitions, divestitures, capital markets activities, or other strategic actions designed to evaluate opportunities to support the Company's long-term strategy and positioning within evolving health and wellness markets.","length":448,"tagName":"p"},{"type":"text","content":"The purpose of the strategic review is to assess whether alignment with emerging trends, technologies, and consumer demand in the health, nutrition, and wellness space may support the Company's long-term strategic objectives. The Company is also evaluating whether the repositioning, expansion, or development of new product platforms or distribution strategies is feasible and commercially viable in both the Canadian marketplace and selected international markets.","length":470,"tagName":"p"},{"type":"text","content":"No decision has been made to pursue any transaction, restructuring, business transition, or other strategic initiative at this time. There can be no assurance that the strategic review will result in any specific outcome, recommendation, or change to the Company's current operations. The Company has not established a timetable for completion of the review and does not intend to comment further unless required under applicable Canadian securities laws, including National Instrument 51-102 - Continuous Disclosure Obligations, National Policy 51-201 - Disclosure Standards, or the policies of the Canadian Securities Exchange.","length":633,"tagName":"p"},{"type":"text","content":"Management Changes","length":18,"tagName":"p"},{"type":"text","content":"The Company also announces the appointment of Anthony Franco as a director and Chief Executive Officer of the Company.","length":118,"tagName":"p"},{"type":"text","content":"Mr. Franco is a seasoned Operation...